Nothing goes up in a straight line, not even during the holidays, so a near-term market pullback would be a healthy way to prevent a steeper correction in January.

It has been an eventful year in the big pharma and biotech space, and a lot is happening in this space that biotech investors should take note of.

Dividend-paying stocks do better than their non-dividend-paying peers.

Today I used Barchart to sort a list of Wall Street's highly recommended stocks to find the 5 with the best technical buy signals.

NASDAQ 100, 5 stocks with the best technical buy signals.

PFE posted stronger than expected quarterly results, helped by growing sales of its cancer drugs and increase in demand in emerging markets.